The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid tumor Opdivo (nivolumab) ...
On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), ...
During a Case-Based Roundtable® event, Daniel J. George, MD, discusses how often community oncology participants see patients ...
Monoclonal Antibodies IndustryThe global monoclonal antibodies (mAbs) industry, valued at USD 186 billion in 2021, is ...
CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satricabtagene autoleucel (satri-cel) has shown efficacy in gastric cancer, in a rare win for this type of cell therapy in a solid ...
Halozyme provides subcutaneous drug delivery solutions, with several major new products recently approved. Click here to find ...
California Resident Sues 3 Asia-Based Banks for Failing to Prevent Crypto Scam Resulting in $1M Loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback